GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (TSXV:NRX) » Definitions » Net Policyholder Benefits/Claims

NurExone Biologic (TSXV:NRX) Net Policyholder Benefits/Claims


View and export this data going back to 2022. Start your Free Trial

What is NurExone Biologic Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


NurExone Biologic Business Description

Industry
Traded in Other Exchanges
Address
1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
NurExone Biologic Inc is a company that focuses on developing biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the biopharmaceutical industry for other diseases and indications.
Executives
James Angus Wilson (bilkstys-) Richardson 10% Security Holder, Director, Senior Officer